Hsa-miR-34c suppresses growth and invasion of human laryngeal carcinoma cells via targeting c-Met

International Journal of Molecular Medicine

Volumn 25, Issue 4, 2010, Pages 565-571

  Cai, Ke Min ^a   Bao, Xue Li ^a   Kong, Xu Hui ^a   Jinag, Wu ^a   Mao, Ming Rong ^a   Chu, Jiu Sheng ^a   Huang, Yong Jiu ^a   Zhao, Xiao Jun ^a  

^a TAIZHOU PEOPLE S HOSPITAL   (China)

Author keywords

Apoptosis; hsa miR 34c; Invasion; Laryngeal carcinoma; MicroRNA; Proliferation

Indexed keywords

LENTIVIRUS VECTOR; MICRORNA; MICRORNA 34C; SCATTER FACTOR RECEPTOR; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CANCER INVASION; CARCINOMA CELL; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; HUMAN; HUMAN CELL; LARYNX CARCINOMA; PRIORITY JOURNAL;

3' UNTRANSLATED REGIONS; APOPTOSIS; BASE SEQUENCE; BINDING SITES; CELL LINE, TUMOR; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; COMPUTATIONAL BIOLOGY; DNA, COMPLEMENTARY; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LARYNGEAL NEOPLASMS; MICRORNAS; MOLECULAR SEQUENCE DATA; NEOPLASM INVASIVENESS; PROTO-ONCOGENE PROTEINS C-MET;

EID: 77749273844     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm_00000378     Document Type: Article

References (20)

1. Lai EC: microRNAs: runts of the genome assert themselves. Curr Biol 13: R925-R936, 2003.
2. Nelson KM and Weiss GJ: MicroRNAs and cancer: past, present, and potential future. Mol Cancer Ther 7: 3655-3660, 2008.
3. Marioni G, Marchese-Ragona R, Cartei G, Marchese F and Staffieri A: Current opinion in diagnosis and treatment of laryngeal carcinoma. Cancer Treat Rev 32: 504-515, 2006.
4. Liu M, Wu H, Liu T, Li Y, Wang F, Wan H, Li X and Tang H: Regulation of the cell cycle gene, BTG2, by miR-21 in human laryngeal carcinoma. Cell Res 19: 828-837, 2009.
5. Hernando E: microRNAs and cancer: role in tumorigenesis, patient classification and therapy. Clin Transl Oncol 9: 155-160, 2007.
6. Schickel R, Boyerinas B, Park SM and Peter ME: MicroRNAs: key players in the immune system, differentiation, tumorigenesis and cell death. Oncogene 27: 5959-5974, 2008.
7. Xia H, Qi Y, Ng SS, Chen X, Chen S, Fang M, Li D, Zhao Y, Ge R, Li G, Chen Y, He ML, Kung HF, Lai L and Lin MC: MicroRNA-15b regulates cell cycle progression by targeting cyclins in glioma cells. Biochem Biophys Res Commun 380: 205-210, 2009.
8. Asangani IA, Rasheed SA, Nikolova DA, Leupold JH, Colburn NH, Post S and Allgayer H: MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene 27: 2128-2136, 2008.
9. Zhang C, Kang C, You Y, Pu P, Yang W, Zhao P, Wang G, Zhang A, Jia Z, Han L and Jiang H: Co-suppression of miR-221/222 cluster suppresses human glioma cell growth by targeting p27kip1 in vitro and in vivo. Int J Oncol 34: 1653-1660, 2009.
10. Liu X, Yu J, Jiang L, Wang A, Shi F, Ye H and Zhou X: MicroRNA-222 regulates cell invasion by targeting matrix metalloproteinase 1 (MMP1) and manganese superoxide dismutase 2 (SOD2) in tongue squamous cell carcinoma cell lines. Cancer Genomics Proteomics 6: 131-139, 2009.
11. Smith HS, Hackett AJ, Riggs JL, Mosesson MW, Walton JR and Stampfer MR: Properties of epithelial cells cultured from human carcinomas and nonmalignant tissues. J Supramol Struct 11: 147-166, 1979.
12. Shi L, Cheng Z, Zhang J, Li R, Zhao P, Fu Z and You Y: hsa-mir-181a and hsa-mir-181b function as tumor suppressors in human glioma cells. Brain Res 1236: 185-193, 2008.
13. Liu X, Jiang L, Wang A, Yu J, Shi F and Zhou X: MicroRNA-138 suppresses invasion and promotes apoptosis in head and neck squamous cell carcinoma cell lines. Cancer Lett 286: 217-222, 2009.
14. Cotter TG: Apoptosis and cancer: the genesis of a research field. Nat Rev Cancer 9: 501-507, 2009.
15. Ward JA, Huang L, Guo H, Ghatak S and Toole BP: Perturbation of hyaluronan interactions inhibits malignant properties of glioma cells. Am J Pathol 162: 1403-1409, 2003.
16. Behrens J, Mareel MM, Van Roy FM and Birchmeier W: Dissecting tumor cell invasion: epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cell-cell adhesion. J Cell Biol 108: 2435-2447, 1989.
17. You WK and McDonald DM: The hepatocyte growth factor/c-Met signaling pathway as a therapeutic target to inhibit angiogenesis. BMB Rep 41: 833-839, 2008.
18. Maulik G, Shrikhande A, Kijima T, Ma PC, Morrison PT and Salgia R: Role of the hepatocyte growth factor receptor, c-Met, in oncogenesis and potential for therapeutic inhibition. Cytokine Growth Factor Rev 13: 41-59, 2002.
19. Sawatsubashi M, Sasatomi E, Mizokami H, Tokunaga O and Shin T: Expression of c-Met in laryngeal carcinoma. Virchows Arch 432: 331-335, 1998.
20. Yücel OT, Sungur A and Kaya S: c-met overexpression in supraglottic laryngeal squamous cell carcinoma and its relation to lymph node metastases. Otolaryngol Head Neck Surg 130: 698-703, 2004.